genera life sciences

HCV HIV Antigens, Therapeutic Proteins, Diagnostic Kits, Chymosin. Dossiers for Cancer, Metered Dose Inhalers, Dry Powder Inhalers, Steroids, Cephalosporins. In-licensing - NDDS-oral,parenterals. Indian Representation for Multinational patented Products. Life-saving drugs-Geftinib,Imatinib,Bortezomib,Temozolomide,Altretamine.Clinical Trials, CT Packaging

Activity:

- Clinical Trials
- Contract Manufacturing
- Contract Research
- Licensing & Business Development
- Manufacturing
- Market Research & Marketing
- Regulatory Affairs & Legal Services
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Cosmoceuticals
- Devices
- Diagnostics
- Drug delivery
- Enzymes
- Generics
- FP (finished products)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Phyto
- Nutritionals / Vitamins
- Prescription drugs (Rx)
- Proteins
- Reagents
- Technology

Therapeutic targets:

- Asthma
- Cancer
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Gastrointestinal
- Genetics
- Hematology
- Infectious Diseases
- Neurology
- Oncology
- Orthopedics
- Respiratory Medicine
- Transplant
- Urology

Markets Covered

a. HeadQuarter: India

b. Continent(s) active: Europe , North America , Near/Middle East , Australia/New-Zealand , Africa , Central/South America , Asia , Far East

c. Countries active: USA, Germany, UK, Ireland, Spain, Poland, Greece, Austria, Austria, Hungary, Slovenia, Czech, Croatia, Portugal, Macedonia, Netherlands, Canada

Corporate data:

Number of Employees: 10

Turnover:

Amount:	Year:	Currency:
1	2006	US Dollar

Year founded: 2006

Partners / Alliances: Pharma Network, USA
Delfarma, Poland